Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes

Biochemical and Biophysical Research Communications - Tập 430 - Trang 827-832 - 2013
Huaping Shi1, Lei Chen2, Huilan Wang3,4, Shoukang Zhu5, Chunming Dong5, Keith A. Webster3,4, Jianqin Wei5,3,4
1Hangzhou Red Cross Hospital, Zhejiang, China
2Sir-Run-Run Shaw Hospital, Zhejiang, China
3Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, FL, United States
4Vascular Biology Institute, Miller School of Medicine, University of Miami, Miami, FL, United States
5Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States

Tài liệu tham khảo

Gardin, 2004, Left ventricular hypertrophy: the next treatable, silent killer?, JAMA, 292, 2396, 10.1001/jama.292.19.2396 McKinsey, 2012, Therapeutic potential for HDAC inhibitors in the heart, Ann. Rev. Pharmacol. Toxicol., 52, 303, 10.1146/annurev-pharmtox-010611-134712 Antos, 2003, Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors, J. Biol. Chem., 278, 28930, 10.1074/jbc.M303113200 Kook, 2003, Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein hop, J. Clin. Invest., 112, 863, 10.1172/JCI19137 Kee, 2006, Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding, Circulation, 113, 51, 10.1161/CIRCULATIONAHA.105.559724 Kong, 2006, Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy, Circulation, 113, 2579, 10.1161/CIRCULATIONAHA.106.625467 Backs, 2006, CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy, J. Clin. Invest., 116, 1853, 10.1172/JCI27438 Zhang, 2002, Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy, Cell, 110, 479, 10.1016/S0092-8674(02)00861-9 Chang, 2004, Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development, Mol. Cell. Biol., 24, 8467, 10.1128/MCB.24.19.8467-8476.2004 Backs, 2006, CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy, J. Clin. Invest., 116, 1853, 10.1172/JCI27438 Vega, 2004, Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5, Mol. Cell. Biol., 24, 8374, 10.1128/MCB.24.19.8374-8385.2004 Bradner, 2010, Chemical phylogenetics of histone deacetylases, Nat. Chem. Biol., 6, 238, 10.1038/nchembio.313 Heltweg, 2012, Subtype selective substrates for histone deacetylases, J. Med. Chem., 47, 5235, 10.1021/jm0497592 Kee, 2009, Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy, J. Mol. Cell. Cardiol., 47, 770, 10.1016/j.yjmcc.2009.08.022 Liao, 2010, Kruppel-like factor 4 regulates pressure-induced cardiac hypertrophy, J. Mol. Cell. Cardiol., 49, 334, 10.1016/j.yjmcc.2010.04.008 Glenn, 2009, Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2, Hypertension, 53, 549, 10.1161/HYPERTENSIONAHA.108.125088 Chandrasekaran, 2009, Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes, FASEB J., 23, 3851, 10.1096/fj.09-132415 Cao, 2009, Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy, Proc. Natl. Acad. Sci. USA, 108, 4123, 10.1073/pnas.1015081108 Iyer, 2010, Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats, Br. J. Pharmacol., 159, 1408, 10.1111/j.1476-5381.2010.00637.x Lee, 2007, Inhibition of histone deacetylase on ventricular remodeling in infarcted rats, Am. J. Physiol. Heart Circ. Physiol., 293, 968, 10.1152/ajpheart.00891.2006 Granger, 2008, Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice, FASEB J., 22, 3549, 10.1096/fj.08-108548 Zhao, 2007, Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury, Cardiovasc. Res., 76, 473, 10.1016/j.cardiores.2007.08.010 Osman, 2012, Micro-RNAs in health and disease-basic science and clinical applications, Clin. Lab., 58, 393 Papageorgiou, 2012, The role of micro-RNAs in cardiovascular disease, Curr. Med. Chem., 19, 2605, 10.2174/092986712800493048 Salloum, 2010, Role of micro-RNAs in cardiac preconditioning, J. Cardiovasc. Pharmacol., 56, 581, 10.1097/FJC.0b013e3181f581ba Fish, 2008, miR-126 regulates angiogenic signaling and vascular integrity, Dev. Cell, 15, 272, 10.1016/j.devcel.2008.07.008 Wang, 2008, The endothelial-specific micro-RNA miR-126 governs vascular integrity and angiogenesis, Dev. Cell, 15, 261, 10.1016/j.devcel.2008.07.002 Kuhnert, 2008, Attribution of vascular phenotypes of the murine Egfl7 locus to the micro-RNA miR-126, Development, 135, 3989, 10.1242/dev.029736 Wakioka, 2001, Spred is a sprouty-related suppressor of ras signalling, Nature, 412, 647, 10.1038/35088082 Ueki, 2003, Positive and negative roles of p85α and p85β regulatory subunits of phosphoinositide 3-kinase in insulin signaling, J. Biol. Chem., 278, 48453, 10.1074/jbc.M305602200 Badiwala, 2010, Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells, Circulation, 122, 156, 10.1161/CIRCULATIONAHA.109.927715 Gustavsson, 2007, Vascular response to hypoxic preconditioning in the immature brain, J. Cereb. Blood Flow Metab., 27, 928, 10.1038/sj.jcbfm.9600408 Webster, 1999, Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53, J. Clin. Invest., 104, 239, 10.1172/JCI5871 Kubasiak, 2002, Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3, Proc. Natl. Acad. Sci. USA, 99, 12825, 10.1073/pnas.202474099 Zhao, 2002, Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo, Basic Res. Cardiol., 97, 348, 10.1007/s00395-002-0360-0 Wilson, 2010, Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells, BMC Genom., 11, 229, 10.1186/1471-2164-11-229 Jason, 2009, Fish and Deepak Srivastava microRNAs: opening a new vein in Sci Signal, Sci. Signal., 2, 252 Xiao, 2010, SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice, J. Biol. Chem., 285, 36776, 10.1074/jbc.M110.168039 Zhong, 2010, Raul mostoslavsky the histone deacetylase SIRT6 regulates glucose homeostasis via Hif1α, Cell, 140, 280, 10.1016/j.cell.2009.12.041 Kato, 2004, Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity, J. Biol. Chem., 279, 41966, 10.1074/jbc.M406320200 Oka, 2008, Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure, J. Circ., 72 Suppl A, A13, 10.1253/circj.CJ-08-0481 Russell, 2012, Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease, ACS Chem. Biol., 7, 1077, 10.1021/cb300001m